APA

Murosaki S., Inagaki J., Horikoshi N., Esaki K., Inoue K., Nagura E., Ueoka H., Takano Y., Kobayashi T., Okabe K. & Ogawa M. (19811014). [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)]. : Nihon Gan Chiryo Gakkai shi.

Chicago

Murosaki S, Inagaki J, Horikoshi N, Esaki K, Inoue K, Nagura E, Ueoka H, Takano Y, Kobayashi T, Okabe K and Ogawa M. 19811014. [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)]. : Nihon Gan Chiryo Gakkai shi.

Harvard

Murosaki S., Inagaki J., Horikoshi N., Esaki K., Inoue K., Nagura E., Ueoka H., Takano Y., Kobayashi T., Okabe K. and Ogawa M. (19811014). [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)]. : Nihon Gan Chiryo Gakkai shi.

MLA

Murosaki S, Inagaki J, Horikoshi N, Esaki K, Inoue K, Nagura E, Ueoka H, Takano Y, Kobayashi T, Okabe K and Ogawa M. [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)]. : Nihon Gan Chiryo Gakkai shi. 19811014.